Skip to content

Ayahuasca: all studies

Page 134 of 167: studies 1,331 to 1,340 of 1,661, newest first. Back to the ayahuasca overview

Research

Hepatitis B Vaccination in Psychiatric patients in Morocco

European Psychiatry March 1, 2023 E. Prades, A. Torres, P. Díez et al. 1 citation

Introduction Ayahuasca is a traditional brew containing the psychedelic 5-DMT (a tryptamine that acts as a 5HT2A-R agonist) used to achieve non-ordinary states of consciousness, with a long tradition among various cultures in ritual and therapeutic contexts. Ayahuasca is being studied as potential treatment in Mental Health, which has led to non-controlled and recreational use. This has led to...

Information parity increases on functional brain networks under influence of a psychedelic substance

Journal of Physics: Complexity March 1, 2023 Aline Viol, G. M. Viswanathan, Oleksandra Soldatkina et al. 4 citations

Abstract The physical basis of consciousness is one of the most intriguing open questions that contemporary science aims to solve. By approaching the brain as an interactive information system, complex network theory has greatly contributed to understand brain process in different states of mind. We study a non-ordinary state of mind by comparing resting-state functional brain networks of...

DOI: 10.1088/2632-072x/acc22b (opens in new tab) Pairwise comparison Consciousness Resting State FMRI Parity physics +3

Psychedelics for depression: from neurobiology to treatment

European Psychiatry March 1, 2023 K. P. Kuypers 2 citations

Abstract Decades ago, the classical psychedelics psilocybin and LSD entered the therapeutic setting and already then showed their therapeutic potential in the treatment of psychiatric disorders. For thousands of years another psychedelic, ayahuasca, is being used by tribes in western Amazonia for healing and divination, and in recent years its use has expanded worldwide. Research into the...

DOI: 10.1192/j.eurpsy.2023.74 (opens in new tab) Full text (opens in new tab) Psilocybin Psychotherapist Therapeutic effect Therapeutic approach +3

Intersubjectivity and bodies: The fluidity and the limits of consciousness

Anthropology of Consciousness February 27, 2023 Christian Frenopoulo 4 citations

The articles in this issue reflect an important paradox. The ethnographic research presented in these articles suggest that consciousness is formed socially and in interaction with environmental factors and, to some extent, is a learned attribute. In that sense, it would be fluid, malleable, and processual. On the other hand, there is evidence that it has some intrinsic boundaries, such that...

DOI: 10.1111/anoc.12173 (opens in new tab) Consciousness Intersubjectivity Citation Anthropology +3

Intersecting Cultures

February 27, 2023 Emma Garrod, Katrina Blommaert 2 citations

Ayahuasca has experienced a meandering legal and ethical journey in Canada. The health and spiritual benefits of this medicine are profound, yet it is paramount to consider the implications of its use in places far removed from its endemic regions. In Canada, under the Controlled Drugs and Substances Act (CDSA), N,N-dimethyltryptamine (DMT) and harmaline, two ingredients in ayahuasca, are both...

Beyond Phytochemistry

February 6, 2023 Felix Krengel, Ricardo Reyes-Chilpa, Karla Paola García-Cruz et al.

The shrub Tabernanthe iboga (Apocynaceae) has great ethnomedical and spiritual importance in Central Africa due to its stimulant and oneirogenic properties, which can be attributed to the presence of ibogan type alkaloids, particularly ibogaine. Several Mexican Tabernaemontana (Apocynaceae) species also produce ibogaine type alkaloids and are used in traditional medicine against dermatological...

The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials.

European Archives of Psychiatry and Clinical Neuroscience February 1, 2023 Giordano Novak Rossi, Jaime E. C. Hallak, Glen B. Baker et al. 14 citations

Although results are still preliminary, ketamine and classical hallucinogens have shown promise in recent years as novel, fast-acting antidepressants, especially for the treatment of unipolar treatment-resistant depression (TRD). Depression also seems to be related to abnormal levels of peripheral inflammatory and neurotrophic biomarkers, which may one day help to diagnose of this disorder. In...

Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health

Advances in Research January 30, 2023 Jennings Hernandez

Roughly over 700 million individuals suffer from a mental illness globally. In the United States alone, over 45 million individuals are afflicted with a mental disorder at any given point in their lives. It is because of this that new methods of current therapies should be considered. To date, major depression disorder (MAD), anxiety, and post-traumatic stress disorder (PTSD) are treated with...

Psychedelics for Patients With Cancer: A Comprehensive Literature Review

Annals of Pharmacotherapy January 12, 2023 C Michael White, Nissen Weisman, Joseph Dalo 18 citations

Objective: To assess the role of psychedelics in the treatment of anxiety or depression among patients with cancer. Data Sources: PubMed search from inception to March 11, 2022, using the terms anxiety, depression, psychedelics, psilocybin, lysergic acid, methylenedioxymethamphetamine, or ayahuasca. Study Selection and Data Extraction: Studies assessing patients with cancer receiving...

Vizionáriusok vs. szakértők

Kultúra és Közösség 2023 Orsolya Bajusz 1 citation

Tanulmányom a tanító (pszichoaktív) növények és a szakértők (pszichológusok) konfliktusának kibontásán keresztül a tudás, közvetítés különböző módozatainak ideológiai beágyazottságával, ezen keresztül világnézetek és különféle tudások konfliktusával foglalkozik, különösen a szubjektív, vizionárius tapasztalatra fókuszálva. A növények értelemszerűen nem ‘szakértőként’, tényeket és adatokat...